Skip to main content
Quest Diagnostics

Prevalence and Relative Distributions of Major Phosphatidylethanol (PEth) Homologs in a Large-Scale Clinical Study

AACC/ADLM 2024

The Association for Diagnostics & Laboratory Medicine (formerly ACC)

Chicago, IL, July 28-Aug 1, 2024

Poster presentation: Prevalence and Relative Distributions of Major Phosphatidylethanol (PEth) Homologs in a Large-Scale Clinical Study 

Authors: Dui W, Smith MP, Bartock SH

Specialty: Prescription drug monitoring, toxicology

Related content

Audio Podcast
Phosphatidylethanol (PEth) blood test - Now available from Quest Diagnostics
Test FAQ
Drug monitoring, Phoshatidylethanol (PEth), Blood Test
Conference Presentation
Early insights from a pharmacogenomic enriched comprehensive medication management program implementation in an adult employee population
Audio Podcast
Implementing a Drug Monitoring Protocol in your practice

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.